Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds

ICMR sees potential in ‘immunity-booster’ BCG

Tribune Web Desk

Updated At : 12:50 PM Oct 30, 2020 IST

New Delhi, October 29

Bacillus Calmette-Guerin (BCG), the 1921 anti-tuberculosis vaccine, could have potential utility in Covid-19 management as it enhances immunity among the elderly, a new research has found.

The study by the ICMR followed 86 healthy elderly individuals aged 60 to 80 years a month after BCG vaccination and found the jab enhanced all kinds of antibodies in the target group. A section of researchers cites BCG shots as a contributing factor for lower Covid mortality among Indians. — TNS

Live Matches

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by :

ICMR sees potential in ‘immunity-booster’ BCG

Tribune Web Desk

Unlock Exclusive Insights with The Tribune Premium

Live Matches